优秀女子举重运动员新发2型糖尿病治疗后重返赛场1例报告  

A Case Report of an Elite Female Weightlifter Return to Competition after Treatment of New Onset Type 2 Diabetes Mellitus

作　　者：白云飞[1] 张剑梅 李璟[1] 周敬滨[1] 丁雨[1] 张瑞平 BAI Yunfei;ZHANG Jianmei;LI Jing;ZHOU Jingbin;DING Yu;ZHANG Ruiping(National Institute of Sports Medicine,Beijing 100076,China)

机构地区：[1]国家体育总局运动医学研究所,北京100076

出　　处：《体育科研》2022年第5期100-104,共5页Sport Science Research

摘　　要：报告了1则主诉“运动时乏力2个月”的女子举重运动员(87 kg级)因影响训练和比赛成绩就诊后,经诊治恢复机体状态并重返赛场的病例。临床结合患者相关检查和危险因素分析(肥胖、家族史等),诊断为2型糖尿病。考虑运动员项目特点,为保持其体重和体能,予以磷酸西格列汀片100 mg联合盐酸吡格列酮片15 mg口服、每日1次的治疗。此外,患者接受营养和运动训练调整使血糖保持平稳,安全地恢复训练和比赛。通过分析该病例,尝试对女子举重运动员的糖尿病发病特点、治疗方案及相关运动能力进行初步分析,为后续进一步探究相关诊疗及重返赛场的队列研究提供思路。The paper reported a female weightlifter(87 kg class) who complained of fatigue during exercise for 2 months was treated for affecting the performance of training and competition. And she recovered her physical state and returned to the competition after diagnosis and treatment. Type 2 diabetes was diagnosed by clinical examination and risk factor analysis(obesity, family history, etc.). Considering the characteristicsofathletes, in orderto maintain their weight and physical fitness, sitagliptin phosphate 100 mg combined with pioglitazone hydrochloride 15 mg orally(once a day). In addition, the patient received nutritional and exercise training adjustments to keep their blood sugar levels stable and safely return to training and competition. Through the analysis of this case, the characteristics of diabetes, treatment plan and related exercise ability of female weightlifters were attempted to make a preliminary analysis, so as to provide ideas for further research on related diagnosis and treatment and the cohort study of returning to competition.

关 键 词：举重 2型糖尿病 重返赛场 

分 类 号：G804[文化科学—运动人体科学]